Pamidronate treatment of severe osteogenesis imperfecta in a newborn infant

Journal of Inherited Metabolic Disease

Volumn 25, Issue 7, 2002, Pages 593-595

  Chien, Y H ^a   Chu, S Y ^a   Hsu, C C ^a   Hwu, W L ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CALCIUM DERIVATIVE; PAMIDRONIC ACID; PARATHYROID HORMONE; PHOSPHATE; VITAMIN D;

ARTICLE; BLOOD CHEMISTRY; BONE DENSITY; BONE GROWTH; BONE MALFORMATION; BONE PAIN; BONE RADIOGRAPHY; CALCIUM BLOOD LEVEL; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; FRACTURE; FRACTURE EXTERNAL FIXATION; HUMAN; HYPOCALCEMIA; INFANT FEEDING; NEWBORN; OSTEOCLAST; OSTEOGENESIS IMPERFECTA; OSTEOPENIA;

DIPHOSPHONATES; FEMALE; HUMANS; INFANT, NEWBORN; LEG BONES; OSTEOGENESIS IMPERFECTA;

EID: 0036880949     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022099425316     Document Type: Article

References (3)

1. Allgrove J (1997) Bisphosphonates. Arch Dis Child 76: 73-75.
2. Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R (1998) Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med 339: 947-952.
3. Plotkin H, Rauch F, Bishop NJ, et al (2000) Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age. J Clin Endocrinol Metab 85: 1846-1850.